Gotham Asset Management’s Insys Therapeutics, Inc. INSY Stock Holding History

Gotham Asset Management’s Portfolio INSY Stock Details INSY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-70,484	Closed	-$892K	–	1099
2017 Q2	$892K	Sell	70,484 -128,090	-65%	-$1.52M	0.01%	655
2017 Q1	$2.09M	Sell	198,574 -8,481	-4%	-$90.4K	0.03%	544
2016 Q4	$1.91M	Sell	207,055 -120,005	-37%	-$1.36M	0.02%	517
2016 Q3	$3.86M	Sell	327,060 -616,900	-65%	-$9.38M	0.05%	398
2016 Q2	$12.2M	Sell	943,960 -121,350	-11%	-$1.77M	0.15%	229
2016 Q1	$17M	Buy	1,065,310 +234,770	+28%	+$4.46M	0.19%	178
2015 Q4	$23.8M	Buy	+830,540	New	+$23M	0.26%	132
2014 Q3	–	Sell	-60,222	Closed	-$940K	–	1103
2014 Q2	$940K	Buy	60,222 +26,258	+77%	+$424K	0.01%	659
2014 Q1	$704K	Sell	33,964 -14,360	-30%	-$285K	0.01%	725
2013 Q4	$624K	Buy	+48,324	New	+$670K	0.01%	712

Other funds holding INSY

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $299B AUM 28.69% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

FHAM

Folger Hill Asset Management New York $16.5M AUM 19.96% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Gotham Asset Management's INSY Position: Q3 2017 in Review

Gotham Asset Management sold out of Insys Therapeutics, Inc. (INSY) in Q3 2017, closing a stake of 70,484 shares — an estimated $892K sold.

Gotham Asset Management first reported a position in INSY in Q4 2013 and held it in 10 quarters. The position peaked at $23.8M in Q4 2015. 116 funds tracked by Wall St. Rank hold INSY as of Q3 2017.

Gotham Asset Management reported no remaining Insys Therapeutics, Inc. position as of Q3 2017 after selling out during the quarter.
Gotham Asset Management sold 70,484 Insys Therapeutics, Inc. shares in Q3 2017, an estimated $892K.
Gotham Asset Management first reported a position in Insys Therapeutics, Inc. in Q4 2013 and held it in 10 quarters.
Gotham Asset Management's Insys Therapeutics, Inc. position peaked at $23.8M in Q4 2015.
116 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q3 2017.

Based on Gotham Asset Management's 13F filing for Q3 2017, filed 14 Nov 2017.